EXPORT CITATION

Chapter-07 Summary of Guidelines on Premature Menopause, Endometriosis and Polycystic Ovarian Disease

BOOK TITLE: Manual of Clinical Dilemma in Mature Women

Author
1. Meeta
2. Unni Jyothi
ISBN
9789352703739
DOI
10.5005/jp/books/18026_8
Edition
1/e
Publishing Year
2018
Pages
4
Author Affiliations
1. Tanvir Hospital, Hyderabad, Andhra Pradesh, India, Tanvir Hospital, Hyderabad, Telangana, India
2. Jehangir Hospital, Pune, Maharashtra, India
Chapter keywords
Premature menopause, endometriosis, polycystic ovarian disease, premature ovarian insufficiency, POI, follicular stimulating hormone, FSH, polycystic ovarian syndrome, hyperandrogenism, hyperinsulinemia, dyslipidemia

Abstract

This chapter describes the summary of guidelines on premature menopause, endometriosis and polycystic ovarian disease. Premature ovarian insufficiency (POI) (also known as premature menopause) is defined as primary hypogonadism before the age of 40 years in women with a normal karyotype who previously had normal menstrual cycles. The diagnosis of POI is confirmed by the finding of follicular stimulating hormone (FSH) levels 40 IU/l on two occasions 4–6 weeks apart. In contrast to the treatment of postmenopausal osteopenia or osteoporosis, which focuses on bisphosphonates as first-line therapy, low bone mass in women with primary ovarian insufficiency is managed most appropriately with HT—ACOG. Polycystic ovarian syndrome (PCOS) is the single most common endocrine metabolic disorder of humans, affecting up to 15% of women. It is characterized by chronic oligo- or anovulation, hyperandrogenism, hyperinsulinemia, dyslipidemia, and metabolic syndrome.

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved

Powered by MPS ScholarStor